Online Program Home
  My Program
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Activity Details

533 Wed, 8/2/2017, 12:30 PM - 1:50 PM CC-Ballroom II
Biopharmaceutical Section P.M. Roundtable Discussion (Added Fee) — Roundtables PM Roundtable Discussion
Biopharmaceutical Section
Organizer(s): Qi Jiang, Amgen Inc.
WL08: Aggregate Safety Monitoring for the FDA IND Safety Reporting Final Rule Greg Ball, Merck
WL09: Statistical Considerations for Rare Disease Clinical Development Yang Song, Vertex Pharmaceuticals
WL10: Statistical Inference in the Era of Precision Medicine- the Essential Role of Statistics for Unmet Needs in Algorithm Refinement, Diagnostics Application and Drug Development Ruixiao Lu, Genomic Health
WL11: Beyond the Statistical Analysis Plan: Statisticians Partaking Earlier in Design of Clinical Trials Yuqun Abigail Luo, FDA
WL12: Unblinded Sample Size Re-Estimation for Complex Trials Chris Holland, Amgen
Copyright © American Statistical Association